Efficacy of Amlodipine in Pediatric Bone Marrow Transplant Patients

Abstract

The calcium antagonist amlodipine may have the potential for expanded use in children owing to its physiochemistry and pharmacokinetic profile that facilitates once-daily dosing in a liquid formulation. Its safety and efficacy have not been previously evaluated in children. A retrospective analysis of 15 pediatric bone marrow transplant patients who had amlodipine incorporated into their antihypertensive drug regimen reveals significantly lower blood pressure as compared with baseline therapy (123.5 ±2.1 mmHg and 117.2 ±2.2 mmHg, systolic blood pressure before and during amlodipine, P<0.05; 81.5 +1.8 mmHg and 75.5 ±2.6 mmHg, diastolic blood pressure before and during amlodipine, P<0.05). Amlodipine provided improved blood pressure control in this cohort and may provide a valuable pharmacologic alternative for treatment of pediatric hypertension.

Get full access to this article

View all access options for this article.

References

1. Kaplan RA , Hellerstein S , Alon U . Evaluation of the hypertensive child. Child Nephrol Urol. 1992;12:106-112.

2. Hiner LB , Falkner B . Renovascular hypertension in children. Pediatr Clin North Am. 1993;40:123-140.

3. Rocchini AP . Cardiovascular causes of systemic hypertension. Pediatr Clin North Am. 1993;40:141-147.

4. Rodd CJ , Sockalosky IJ . Endocrine causes of hypertension in children. Pediatr Clin North Am. 1993;40:149-164.

5. Barret AJ , et al. Cyclosporine A as prophylaxis against graft-versus-host disease in 36 patients. Br Med J. 1982; 285:162-166.

6. Loughran TP , Deeg HJ , Dahlberg A , et al. Incidence of hypertension after marrow transplantation among 112 patients randomized to either cyclosporine or methotrexate as graftversus-host disease prophylaxis. BrJ Hematol. 1985;59:547-553.

7. Abernethy DR , Gutkowski J , Winterbottom LM . Effects of amlodipine, a long-acting dihydropyridine calcium antagonist in aging hypertension: pharmacodynamics in relation to disposition. Clin Pharmacol Ther. 1990; 48:76-86.

8. Abernethy DR . The pharmacokinetic profile of amlodipine. Am HeartJ 1989;118:1100-1103.

9. Hosie J , Bremner DA , Fell PJ , et al. Comparison of early side effects with amlodipine and nifedipine retard in hypertension. Cardiology. 1992;80 (Suppl 1):S4-S9.

10.

10. Thatcher SJ . Medication compliance. Pediatr Clin North Am. 1981;28:5-21.

11.

11. Englert R , Beressem P , Von Manteuffel E , et al. Amlodipine compared to nitrendipine for treatment of mild to moderate hypertension. Postgrad Med J 1991;67 (Suppl 5):S35-S37.

12.

12. Rofman BA . Long-term open evaluation of amlodipine versus hydrochlorothiazide in patients with essential hypertension. J Cardiovasc Pharmacol. 1988;12 (Suppl 7):S94-S97.

13.

13. Webster J , Rob OJ , Jeffers TA , et al. Once-daily amlodipine in the treatment of mild to moderate hypertension. J Cardiovasc Pharmacol. 1988;12 (Suppl 7):S72-S75.

14.

14. Frishman WH , Brobyn R , Brown RD , et al. A randomized placebo-controlled comparison of amlodipine to atenolol in mild to moderate systemic hypertension. J Cardiovasc Pharmacol. 1988;12 (Suppl 7):S103-S106.

15.

15. Glasser SP , Chrysant SG , Graves J , et al. Safety and efficacy of amlodipine added to hydrochlorothiazide in patients with mild to moderate hypertension. Am J Hypertens. 1989;2:x154-x157.

16.

16. Burris J , Ames R , Applegate W , et al. Double blind comparison of amlodipine and hydrochlorothiazide in patients with mild to moderate hypertension. J Cardiovasc Phar-nacol. 1988; 12 (Suppl 7):S98-S102.

17.

17. Julius S . Amlodipine in hypertension: an overview of the clinical dossier. J Cardiovasc Pharmacol. 1988;12 (Suppl 7):S27-S33.

18.

18. Jensen H , Garsdal P , Davies J . Amlodipine with enalapril therapy in moderate-severe essential hypertension. JHum Hypertens. 1990;4:541-545.

19.

19. Maclean D , Mitchell ET , Wilcox RG , et al. A double-blind crossover comparison of amlodipine and placebo added to captopril in moderate to severe hypertension. J Cardiovasc Pharmacol. 1988;12 (Suppl 7):S85-S88.

20.

20. Kiowski W , Luscher TF , Linder L , Bfihler FR . Arterial vasodilator effects of the dihydropyridine calcium antagonist amlodipine alone and in combination with verapamil in systemic hypertension. Am J Cardiol. 1990;66: 1469-1473.